Search

David W. Berke-schlessel

Examiner (ID: 6754, Phone: (571)270-3643 , Office: P/1651 )

Most Active Art Unit
1651
Art Unit(s)
1651, 1799
Total Applications
867
Issued Applications
517
Pending Applications
104
Abandoned Applications
260

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19658835 [patent_doc_number] => 20240425900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH [patent_app_type] => utility [patent_app_number] => 18/687075 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18687075 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/687075
METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH Aug 29, 2022 Pending
Array ( [id] => 18391665 [patent_doc_number] => 20230159883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => METHODS AND COMPOSITIONS FOR PRESERVING BACTERIA [patent_app_type] => utility [patent_app_number] => 17/822860 [patent_app_country] => US [patent_app_date] => 2022-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19123 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/822860
Methods and compositions for preserving bacteria Aug 28, 2022 Issued
Array ( [id] => 19815110 [patent_doc_number] => 20250073317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-06 [patent_title] => CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 18/293972 [patent_app_country] => US [patent_app_date] => 2022-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4903 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293972 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/293972
CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES Aug 24, 2022 Pending
Array ( [id] => 19075311 [patent_doc_number] => 11944654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-02 [patent_title] => Bacteriotherapy for clostridium difficile colitis [patent_app_type] => utility [patent_app_number] => 17/886274 [patent_app_country] => US [patent_app_date] => 2022-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 12416 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886274 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/886274
Bacteriotherapy for clostridium difficile colitis Aug 10, 2022 Issued
Array ( [id] => 19513409 [patent_doc_number] => 20240345095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => AN ASSAY FOR DETERMINING GASTROINTESTINAL PERMEABILITY BY DETERMINING A RATIO OF THE CONCENTRATION OF LACTULOSE TO THE CONCENTRATION OF GALACTOSE IN THE BLOOD SAMPLE [patent_app_type] => utility [patent_app_number] => 18/294793 [patent_app_country] => US [patent_app_date] => 2022-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294793 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/294793
AN ASSAY FOR DETERMINING GASTROINTESTINAL PERMEABILITY BY DETERMINING A RATIO OF THE CONCENTRATION OF LACTULOSE TO THE CONCENTRATION OF GALACTOSE IN THE BLOOD SAMPLE Jul 20, 2022 Pending
Array ( [id] => 19479767 [patent_doc_number] => 20240327809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => Enzymes and Uses Thereof [patent_app_type] => utility [patent_app_number] => 18/578768 [patent_app_country] => US [patent_app_date] => 2022-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578768 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/578768
Enzymes and Uses Thereof Jul 14, 2022 Pending
Array ( [id] => 18228267 [patent_doc_number] => 20230067261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS [patent_app_type] => utility [patent_app_number] => 17/861912 [patent_app_country] => US [patent_app_date] => 2022-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861912 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/861912
METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS Jul 10, 2022 Abandoned
Array ( [id] => 18124495 [patent_doc_number] => 20230010107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-12 [patent_title] => PROCESS FOR PRODUCING PLATELET-RICH FIBRIN MATRIX FROM PLATELET-RICH PLASMA [patent_app_type] => utility [patent_app_number] => 17/861764 [patent_app_country] => US [patent_app_date] => 2022-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861764 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/861764
PROCESS FOR PRODUCING PLATELET-RICH FIBRIN MATRIX FROM PLATELET-RICH PLASMA Jul 10, 2022 Pending
Array ( [id] => 18418583 [patent_doc_number] => 20230173041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/856121 [patent_app_country] => US [patent_app_date] => 2022-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856121 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/856121
NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS Jun 30, 2022 Abandoned
Array ( [id] => 20599021 [patent_doc_number] => 20260077024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-19 [patent_title] => AGENT FOR IMPROVING INTESTINAL FLORA [patent_app_type] => utility [patent_app_number] => 18/579230 [patent_app_country] => US [patent_app_date] => 2022-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18579230 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/579230
AGENT FOR IMPROVING INTESTINAL FLORA Jun 19, 2022 Pending
Array ( [id] => 18162784 [patent_doc_number] => 20230029377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => METHODS AND COMPOSITIONS TO PROMOTING RETINAL REGENERATION USING PROX1 MIGRATION INHIBITOR AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 17/842610 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842610 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/842610
Methods and compositions to promoting retinal regeneration using prox1 migration inhibitor as active ingredient Jun 15, 2022 Issued
Array ( [id] => 19403978 [patent_doc_number] => 20240287489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => CHITINOLYTIC ENZYME-BASED PLANT PROTECTION AGENTS [patent_app_type] => utility [patent_app_number] => 18/570470 [patent_app_country] => US [patent_app_date] => 2022-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20639 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570470 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/570470
CHITINOLYTIC ENZYME-BASED PLANT PROTECTION AGENTS Jun 14, 2022 Pending
Array ( [id] => 20276808 [patent_doc_number] => 20250302050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-02 [patent_title] => PEST CONTROL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/863109 [patent_app_country] => US [patent_app_date] => 2022-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18863109 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/863109
PEST CONTROL COMPOSITIONS May 30, 2022 Pending
Array ( [id] => 19361174 [patent_doc_number] => 20240263208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => CYTOCHROME P450 ENZYME [patent_app_type] => utility [patent_app_number] => 18/563988 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563988 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563988
CYTOCHROME P450 ENZYME May 25, 2022 Pending
Array ( [id] => 19319596 [patent_doc_number] => 20240241139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => DIAGNOSIS OF AUTISM SPECTRUM DISORDER BY MULTIOMICS PLATFORM [patent_app_type] => utility [patent_app_number] => 18/563900 [patent_app_country] => US [patent_app_date] => 2022-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563900 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563900
DIAGNOSIS OF AUTISM SPECTRUM DISORDER BY MULTIOMICS PLATFORM May 24, 2022 Pending
Array ( [id] => 18019459 [patent_doc_number] => 20220370958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => ANTIBODY CONJUGATED NANOPARTICLE ASSAY AND TREATMENT FOR SARS-CoV-2 [patent_app_type] => utility [patent_app_number] => 17/747322 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747322 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/747322
ANTIBODY CONJUGATED NANOPARTICLE ASSAY AND TREATMENT FOR SARS-CoV-2 May 17, 2022 Abandoned
Array ( [id] => 19318328 [patent_doc_number] => 20240239871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => HYPERSIALYLATING CELLS [patent_app_type] => utility [patent_app_number] => 18/557772 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557772 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/557772
HYPERSIALYLATING CELLS Apr 26, 2022 Pending
Array ( [id] => 17930111 [patent_doc_number] => 20220325236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/727323 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727323 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/727323
Biocompatible conditioned cell medium compositions and uses thereof Apr 21, 2022 Issued
Array ( [id] => 20295237 [patent_doc_number] => 20250320480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => Immunoglobulin Cleaving Enzyme [patent_app_type] => utility [patent_app_number] => 18/287565 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10030 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287565 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/287565
Immunoglobulin Cleaving Enzyme Apr 21, 2022 Pending
Array ( [id] => 17760138 [patent_doc_number] => 20220233750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/721604 [patent_app_country] => US [patent_app_date] => 2022-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2753 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721604 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/721604
Crosslinked soft tissue graft and methods of use thereof Apr 14, 2022 Issued
Menu